Heterotopic pancreas: a clinicopathological study of 184 cases from a single high-volume medical center in China

Yifen Zhang(Nanjing University of Chinese Medicine), Qin Huang(People's Hospital of Xinjiang Uygur Autonomous Region), Jason S. Gold(Memorial Sloan Kettering Cancer Center), Ying Lv(Nanjing Drum Tower Hospital), Qiang Li(Wannan Medical College), Xitai Sun(Nanjing Drum Tower Hospital), Qi Sun(First Affiliated Hospital of Xi'an Jiaotong University)
Human Pathology
May 16, 2016
10.1016/j.humpath.2016.05.004
Cited by 61

Related Papers

MYC/BCL2 protein coexpression contributes to the inferior survival of activated B-cell subtype of diffuse large B-cell lymphoma and demonstrates high-risk gene expression signatures: a report from The International DLBCL Rituximab-CHOP Consortium Program
|Blood|2013|683
Development and validation of a prognostic nomogram for recurrence-free survival after complete surgical resection of localised primary gastrointestinal stromal tumour: a retrospective analysis
|The Lancet Oncology|2009|511
Ultralight Multiwalled Carbon Nanotube Aerogel
|ACS Nano|2010|507
Mutational profile and prognostic significance of TP53 in diffuse large B-cell lymphoma patients treated with R-CHOP: report from an International DLBCL Rituximab-CHOP Consortium Program Study
|Blood|2012|396
Cloning of a new member of the peroxisome proliferator-activated receptor gene family from mouse liver.
|Journal of Biological Chemistry|1993|375